Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul-Aug;73(4):346-352.
doi: 10.3322/caac.21779. Epub 2023 Apr 12.

Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma

Samantha M Ruff  1 , Dayssy A Diaz  2 , Kenneth L Pitter  2 , Bridget C Hartwell  1 , Timothy M Pawlik  1
Affiliations
Free article

Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma

Samantha M Ruff et al. CA Cancer J Clin. 2023 Jul-Aug.
Free article
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Sarcognato S, Sacchi D, Fassan M, et al. Cholangiocarcinoma. Pathologica. 2021;113(3):158-169. doi:10.32074/1591-951x-252
    1. Le Roy B, Gelli M, Pittau G, et al. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Br J Surg. 2018;105(7):839-847. doi:10.1002/bjs.10641
    1. Kato A, Shimizu H, Ohtsuka M, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surg Oncol. 2013;20(1):318-324. doi:10.1245/s10434-012-2312-8
    1. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273-1281. doi:10.1056/nejmoa0908721
    1. Oh DY, He AR, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1(8):EVIDoa2200015. doi:10.1056/evidoa2200015

MeSH terms